glp-1 drugs addiction IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target What to know about how
Description
Early results have made it a focus due to its impact on weight, blood sugar, and fat, particularly in adults with obesity or type 2 diabetes
Lorcaserin (Belviq) : Focuses on serotonin receptors to influence appetite
How do Zepbound and Wegovy work to promote weight loss
adults is using these drugs to fight obesity, Statista reported, citing Gallup surveys showing that 12.4% of adults reported taking a GLP-1 drug for weight loss in mid to late 2025 versus 5.8% in February 2024
These fatty acids freely circulate and access heart, skeletal muscle, kidneys and liver [29]
